Clinical Trial Update: A Study of ICP-192 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for ICP-192 in advanced solid tumors and urothelial carcinoma (Phase 1/2). Status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Solid Tumors
• Urothelial Carcinoma

Drugs mentioned

• ICP-192

Snippet

Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. | Conditions: Advanced Solid Tumors, Urothelial Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN